Dismantling Buprenorphine Policy Can Provide More Comprehensive Addiction Treatment

NAM Perspect. 2019 Sep 9:2019:10.31478/201909a. doi: 10.31478/201909a. eCollection 2019.
No abstract available

Grants and funding

The views expressed in this paper are those of the authors and not necessarily of the authors’ organizations, the National Academy of Medicine (NAM), or the National Academies of Sciences, Engineering, and Medicine (the National Academies). The paper is intended to help inform and stimulate discussion. It is not a report of the NAM or the National Academies.